Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?

J Clin Oncol. 2005 Aug 1;23(22):5265-7; author reply 5267-8. doi: 10.1200/JCO.2004.00.9837.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Cancer Vaccines / administration & dosage
  • Cancer Vaccines / immunology*
  • Cancer Vaccines / pharmacology*
  • Drug Administration Schedule
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / immunology*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology*

Substances

  • Cancer Vaccines
  • Interleukin-2